HNRNPC-Mediated m6A Epitranscriptomics Drives CD80-Dependent Tubular Dysfunction in Sepsis-Induced AKI

Chenxia Juan1, Xiangling Zhao1, Yuejuan Wang1

  • 1Department of Nephrology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, No. 155 Hanzhong Road, Qinhuai District, Nanjing, 210029, Jiangsu, China.

Inflammation
|November 6, 2025
PubMed

Insights

HNRNPC protein regulates renal cell apoptosis and cytoskeleton in sepsis-associated acute kidney injury (S-AKI) via m6A modification and NF-κB signaling. This pathway, involving CD80, offers potential therapeutic targets for S-AKI.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Renal Physiology

Background:

  • Sepsis-associated acute kidney injury (S-AKI) involves renal tubular cell apoptosis and cytoskeletal abnormalities.
  • The role of m6A modification-dependent proteins in S-AKI pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the function of HNRNPC in S-AKI.
  • To elucidate the molecular mechanisms linking HNRNPC, m6A modification, NF-κB signaling, and CD80 in S-AKI.

Main Methods:

  • Dot blot, cell viability assays, flow cytometry, fluorescent phalloidin staining.
  • RNA sequencing, luciferase reporter assays, Western blot, EMSA, ChIP assays.
  • MeRIP-qPCR, RNA m6A quantification, in vivo experiments.

Main Results:

  • HNRNPC induces renal tubular cell apoptosis and cytoskeletal damage in S-AKI.
  • HNRNPC promotes CD80 expression transcriptionally via m6A-dependent NF-κB regulation.
  • CD80 is crucial for HNRNPC-induced tubular injury.

Conclusions:

  • HNRNPC plays a key role in S-AKI pathogenesis by regulating apoptosis and cytoskeleton.
  • The HNRNPC/m6A/NF-κB/CD80 axis is a critical pathway in S-AKI.
  • HNRNPC and CD80 represent potential therapeutic targets for S-AKI treatment.